Tenet Healthcare Corporation (THC)
NYSE: THC · Real-Time Price · USD
129.46
+3.76 (2.99%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tenet Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 20,972 | 20,548 | 19,174 | 19,485 | 17,640 | 18,479 | Upgrade
|
| Revenue Growth (YoY) | 4.03% | 7.17% | -1.60% | 10.46% | -4.54% | 0.91% | Upgrade
|
| Cost of Revenue | 12,678 | 12,743 | 12,126 | 12,217 | 11,409 | 11,765 | Upgrade
|
| Gross Profit | 8,294 | 7,805 | 7,048 | 7,268 | 6,231 | 6,714 | Upgrade
|
| Selling, General & Admin | 418 | 418 | 412 | 412 | 403 | 344 | Upgrade
|
| Other Operating Expenses | 3,848 | 3,728 | 3,310 | 3,439 | 3,402 | 3,471 | Upgrade
|
| Operating Expenses | 5,107 | 5,016 | 4,563 | 4,706 | 4,662 | 4,665 | Upgrade
|
| Operating Income | 3,187 | 2,789 | 2,485 | 2,562 | 1,569 | 2,049 | Upgrade
|
| Interest Expense | -850 | -901 | -890 | -923 | -1,003 | -985 | Upgrade
|
| Earnings From Equity Investments | 255 | 228 | 216 | 218 | 169 | 175 | Upgrade
|
| Other Non Operating Income (Expenses) | 103 | 26 | 19 | 25 | 10 | 5 | Upgrade
|
| EBT Excluding Unusual Items | 2,695 | 2,142 | 1,830 | 1,882 | 745 | 1,244 | Upgrade
|
| Merger & Restructuring Charges | -99 | -94 | -132 | -77 | -198 | -143 | Upgrade
|
| Gain (Loss) on Sale of Assets | 2,917 | 23 | 1 | 445 | 14 | -15 | Upgrade
|
| Asset Writedown | -29 | -43 | -94 | -8 | -92 | -42 | Upgrade
|
| Legal Settlements | -37 | -47 | -70 | -116 | -44 | -141 | Upgrade
|
| Other Unusual Items | -335 | -364 | -191 | -238 | 246 | -583 | Upgrade
|
| Pretax Income | 5,112 | 1,617 | 1,344 | 1,888 | 671 | 320 | Upgrade
|
| Income Tax Expense | 1,164 | 306 | 344 | 411 | -97 | 160 | Upgrade
|
| Earnings From Continuing Operations | 3,948 | 1,311 | 1,000 | 1,477 | 768 | 160 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 1 | -1 | - | 11 | Upgrade
|
| Net Income to Company | 3,948 | 1,311 | 1,001 | 1,476 | 768 | 171 | Upgrade
|
| Minority Interest in Earnings | -822 | -700 | -590 | -562 | -369 | -386 | Upgrade
|
| Net Income | 3,126 | 611 | 411 | 914 | 399 | -215 | Upgrade
|
| Net Income to Common | 3,126 | 611 | 411 | 914 | 399 | -215 | Upgrade
|
| Net Income Growth | 566.52% | 48.66% | -55.03% | 129.07% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 98 | 102 | 107 | 107 | 105 | 103 | Upgrade
|
| Shares Outstanding (Diluted) | 100 | 105 | 111 | 109 | 106 | 103 | Upgrade
|
| Shares Change (YoY) | -4.90% | -5.17% | 1.79% | 2.17% | 2.77% | -0.46% | Upgrade
|
| EPS (Basic) | 31.78 | 6.01 | 3.84 | 8.56 | 3.80 | -2.08 | Upgrade
|
| EPS (Diluted) | 31.26 | 5.71 | 3.79 | 8.42 | 3.75 | -2.08 | Upgrade
|
| EPS Growth | 614.09% | 50.51% | -54.96% | 124.49% | - | - | Upgrade
|
| Free Cash Flow | 2,393 | 1,623 | 321 | 910 | 2,867 | 563 | Upgrade
|
| Free Cash Flow Per Share | 23.95 | 15.49 | 2.90 | 8.38 | 26.98 | 5.44 | Upgrade
|
| Gross Margin | 39.55% | 37.98% | 36.76% | 37.30% | 35.32% | 36.33% | Upgrade
|
| Operating Margin | 15.20% | 13.57% | 12.96% | 13.15% | 8.89% | 11.09% | Upgrade
|
| Profit Margin | 14.91% | 2.97% | 2.14% | 4.69% | 2.26% | -1.16% | Upgrade
|
| Free Cash Flow Margin | 11.41% | 7.90% | 1.67% | 4.67% | 16.25% | 3.05% | Upgrade
|
| EBITDA | 4,028 | 3,659 | 3,326 | 3,417 | 2,426 | 2,899 | Upgrade
|
| EBITDA Margin | 19.21% | 17.81% | 17.35% | 17.54% | 13.75% | 15.69% | Upgrade
|
| D&A For EBITDA | 841 | 870 | 841 | 855 | 857 | 850 | Upgrade
|
| EBIT | 3,187 | 2,789 | 2,485 | 2,562 | 1,569 | 2,049 | Upgrade
|
| EBIT Margin | 15.20% | 13.57% | 12.96% | 13.15% | 8.89% | 11.09% | Upgrade
|
| Effective Tax Rate | 22.77% | 18.92% | 25.60% | 21.77% | - | 50.00% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.